Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemafibrate in Severe Hypertriglyceridemia
NCT03001817Phase 3Completed
- Start
- Nov 2016
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of pemafibrate in severe hypertriglyceridemia (SHTG). Started Nov 2016; status: completed.
02
Drugs
pemafibrate
03
Conditions
severe hypertriglyceridemia (SHTG)
Beyond the preview
Go deeper on NCT03001817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03001817.